Happy Head Review: What to Know Before Buying
Happy Head is a telehealth brand founded by a dermatologist and a hair transplant surgeon. The company sells compounded hair loss topicals with minoxidil, dutasteride capsules and a DNA kit. This Happy Head goes into detail on what products they offer, the cost, and we also check Happy Head’s main claims against clinical trials. We also cover 5 potential concerns: genetic testing, latanoprost, propylene glycol, hydrocortisone and the dutasteride formula.
In the first of 2 crossover studies published in 2016 that compared dutasteride’s absorption from its tablet, standard softgel and hard gelatin capsule forms, the body absorbed 76% as much dutasteride from a tablet as from the softgel, and only 73% as much from a hard gelatin capsule [1]. Telehealth pages rarely report such details, and Happy Head’s pages do not either. The company, founded by dermatologist Dr. Ben Behnam and hair transplant surgeon Dr. Sean Behnam, markets its treatments as some of the strongest available, with up to 8% minoxidil and topical dutasteride.
Happy Head has been one of our top recommendations for years, mainly because it made topical dutasteride easy to obtain. However, the company gradually began making formula choices that we feel are questionable. Those concerns inspired us to cofound Ulo, a US telehealth brand that specializes in hair growth exclusively. That has placed Ulo as a direct competitor to Happy Head, so please consider that as you weigh our observations. We credit Happy Head when the company has earned it, but we have some criticisms, which we back up with research.
Offer ends Friday, November 20
Ulo is better than Happy Head.
Plus up to $120 in free gifts with select plans.
Available if prescribed*
Your plan ships with a bundle of Ulo hair care essentials at no extra cost. Longer plans unlock bigger bundles, while supplies last.
*Only available in the U.S. Prescriptions not guaranteed. Restrictions apply. Off-label products are not endorsed by the FDA. Free gifts included with eligible multi-month plans while supplies last.
Key Takeaways
- Real access to strong drugs. Happy Head offers topical and oral dutasteride and a water-based topical for sensitive scalps, all through dermatologists. The company’s website lists its products’ active strengths.
- Claims go beyond the evidence. Happy Head's claims regarding dihydrotestosterone (DHT) and strength are based on studies of oral and injected dutasteride, while no published trial has actually tested 8% minoxidil topicals or the company's 3-in-1 SuperCapsule.
- Formula combinations add avoidable risk. Combining both dutasteride and minoxidil in SuperCapsule at a fixed dose, or topicals that contain propylene glycol, daily hydrocortisone, or latanoprost, might introduce unnecessary risks.
What Causes Male Pattern Hair Loss?
Androgenic alopecia is a genetic and hormone-driven condition that commonly causes hair loss in men. The main cause for the hair loss is dihydrotestosterone (DHT), a hormone converted from testosterone by an enzyme called 5-alpha reductase. DHT slowly shrinks hair follicles sensitive to the hormone until only thin and short hairs can grow from them [2][3].
A 2017 UK Biobank analysis of over 52,000 men found that there are more than 250 separate genetic regions linked to baldness [4].
Both finasteride and dutasteride help hair loss by lowering DHT, while minoxidil has a different mechanism of action and stimulates follicles [5]. Happy Head has built nearly every product around these three drugs, and we cover how they market their products below.
What Does Happy Head Offer?
Happy Head provides both US men and women with an online assessment and a consultation with a board-certified dermatologist, and the company claims it has delivered more than 1,000,000 custom prescriptions. They sell compounded topicals, oral capsules, shampoos, supplements, a laser helmet and the StrandIQ DNA kit. You get free shipping if you sign up for a prescription plan, which can be paused or canceled at any time. Happy Head also offers a guarantee that refunds the most recent month's supply within 6 months.
|
Product |
Listed ingredients |
One-time price |
Subscription price |
|
TopicalRx Solution: Dutasteride + Minoxidil |
0.3% dutasteride, 8% minoxidil, plus retinoic acid and hydrocortisone |
$89 |
$71.20/month |
|
TopicalRx Solution: Finasteride + Minoxidil |
0.3% finasteride, 8% minoxidil, 0.001% retinoic acid, 1% hydrocortisone |
$79 |
$63.20/month |
|
TopicalRx Sensitive Skin (aqueous) |
0.25% finasteride, 8% minoxidil, 0.001% retinoic acid, 1% hydrocortisone |
$119 |
$95.20/month |
|
Advanced ProBlendRx |
9 medicated ingredients, including 0.25% dutasteride, 0.25% finasteride, 8% minoxidil and 0.005% latanoprost |
$89 |
$71.20/month |
|
SuperCapsule (dutasteride) |
0.5 mg dutasteride, 1.25 mg minoxidil, 2,000 IU vitamin D3 |
$89 |
$62 to $71/month |
|
OralRx Dutasteride |
0.5 mg dutasteride |
$294 for 6 months |
$34 to $42/month |
|
StrandIQ DNA Kit |
Cheek swab genetic report |
$298 |
Not applicable |
The prices above are straight from Happy Head’s product pages as of November, 2026. Many of their plans offer a $49 order price for new customers.
Happy Head does get credit for several points. Firstly, it clearly lists out the strengths of each ingredient on its product pages. Many telehealth companies today don't actually provide this information, so that's refreshing. Happy Head also publishes inactive ingredients for at least some of its topical products. The company offers a water-based formula made specifically for sensitive scalps; their dutasteride is reasonably priced, and they also offer access to dermatologists, not just general practitioners.
TopicalRx Solution: Dutasteride + Minoxidil
Formulation
The page lists 0.3% dutasteride and 8% minoxidil as active ingredients, with retinoic acid and hydrocortisone as the two other primary ingredients. Alcohol (ethanol), propylene glycol and citric acid are the inactive ingredients. You apply 1 mL twice a daily from a 60 mL (2-oz) bottle, and that lasts 30 days at 2 mL per day.

How Does It Work?
Dutasteride blocks 5-alpha reductase types 1 and 2, and finasteride blocks mainly 5-alpha reductase type 2 [2]. Like many medications, minoxidil works better for some people than others, with one reason being because follicles produce different amounts of SULT1A1, the enzyme that activates minoxidil [5]. Retinoic acid (tretinoin) is added because it helps more minoxidil pass through the skin [6].
Clinical Effectiveness
A 2014 trial randomized 917 men to dutasteride, finasteride or placebo for 24 weeks [7]. Results showed that dutasteride 0.5 mg was more effective than finasteride 1 mg at increasing hair count and hair thickness. A 2019 meta-analysis pooled 3 trials with 576 men, and these studies also favored dutasteride on total hair count, with similar rates of side effects involving sexual dysfunction [8].
Topical dutasteride has far less evidence supporting its effectiveness. The largest placebo-controlled trial we found, a 2025 phase II study, randomized 135 men to 0.01%, 0.02% or 0.05% dutasteride solution, oral finasteride or placebo for 24 weeks [9]. Hair counts increased with dose, and the 0.05% dutasteride solution ended up being more effective than oral finasteride. However, the maker of the solution funded the trial, and we found no independent replication, so the results may be biased. We also found no published trial of 0.3% dutasteride with 8% minoxidil. That means the effect of Happy Head's exact formula is unknown.
Does the Science Support Happy Head's Claims?
Claim 1: "Dutasteride is 3x more effective than Finasteride and suppresses DHT levels by 98%."
Conclusion: True, but needs context.
The 98% figure comes from high-dose oral dutasteride. In a 2004 trial of 399 men with an enlarged prostate, 5 mg lowered DHT by 98.4% [10]. The 0.5-mg dose used for hair loss lowered it by 94.7% versus 70.8% for finasteride 5 mg. Happy Head cites a 2017 paper in the Indian Journal of Dermatology, Venereology and Leprology, which matches a 90-man open-label trial. In that study, total hair count rose from 223 to 246 per cm² with dutasteride and from 227 to 231 per cm² with finasteride over 24 weeks [3].
The gap varies by study, however. A 2022 review that pooled trials of several drugs put the 24-week advantage of dutasteride 0.5 mg over finasteride 1 mg at 7.1 hairs/cm² [11]. All of these figures come from the drugs in their pill forms. The DNA kit page claims that 3 in 4 people improved on dutasteride, but the cited study is a pooled review of scalp injections, which is not a treatment option offered by Happy Head [12].
Claim 2: "Happy Head formulations use up to 8% Minoxidil, the strongest available concentration compared to OTC Minoxidil at 5%."
Conclusion: True, but needs context.
Using minoxidil at a higher strength has not been shown to lead to more hair. In a 2021 trial, 90 men were randomized to 5% minoxidil, 10% minoxidil, or placebo for 36 weeks [13]. The group of men taking the 5% solution had larger hair count gains than the 10% solution. The 10% group also experience irritation. We know of no trial comparing 8% with 5% minoxidil, so the benefit of the 8% strength is as yet unproven.
Claim 3: Topicals are "shown by clinical studies to have a lower risk of side effects."
Conclusion: True, but needs context.
The best evidence here is for finasteride. A 2022 phase III trial of 458 men found that a topical finasteride spray lowered blood DHT by 34.5%, while oral finasteride lowered the hormone by 55.6% but with similar hair count gains [14]. For dutasteride, only modest hormone changes were observed in the 2025 phase II trial mentioned earlier [9]. Neither study tested 8% minoxidil, propylene glycol or hydrocortisone, and lower blood levels of the drugs do nothing to prevent scalp side effects.
SuperCapsule and OralRx Dutasteride
Formulation
The SuperCapsule comes in a daily pill with three key ingredients: 0.5 mg of dutasteride, 1.25 mg of minoxidil, and 2,000 IUs of vitamin D3. Standalone OralRx comes in bottles of 30 0.5-mg dutasteride capsules a month, which the page describes as "freshly compounded." The SuperCapsule or the OralRX page don't say whether the capsules are softgels or powder-filled, and the 0.5 mg is the only dutasteride strength listed.

Clinical Effectiveness
A 2021 study of 1,404 patients at several centers found that only 1.7% stopped treatment because of side effects [15]. Also, a 2021 review found that low vitamin D levels are linked with several hair loss disorders, but conclusive evidence that vitamin D supplements correct hair loss is lacking [16]. There haven't been any published studies testing the 3-in-1 capsule itself.
Does the Science Support Happy Head's Claims?
Claim 4: "The strongest 3-in-1 hair growth medication to supercharge hair growth and maintain it."
Conclusion: Potentially misleading.
Both the SuperCapsule and OralRx drugs are well supported, so the pairing makes sense. The wording "strongest" is tough to defend though, as the dose of the capsules are standard or low (0.5 mg dutasteride and 1.25 mg minoxidil). Happy Head hasn’t published any results to date on the combined product, and in this case, doses matter a lot here. A 2006 trial in 416 men found that dutasteride's effect on hair count increased with the dosage [2]. Dutasteride 2.5 mg specifically was shown to be more effective than finasteride dosed at 5 mg at both 12 and 24 weeks.
Ulo offers oral dutasteride as a softgel, with minoxidil dosed separately.
Offer ends Friday, November 20
Ulo is better than Happy Head.
Plus up to $120 in free gifts with select plans.
Available if prescribed*
Your plan ships with a bundle of Ulo hair care essentials at no extra cost. Longer plans unlock bigger bundles, while supplies last.
*Only available in the U.S. Prescriptions not guaranteed. Restrictions apply. Off-label products are not endorsed by the FDA. Free gifts included with eligible multi-month plans while supplies last.
Problems with Happy Head's Approach: 5 Concerns and Our Recommendations
Concern #1: Genetic Testing for Hair Loss Treatments
The StrandIQ DNA kit currently costs $298, down from a listed $349. It provides a report on 33 hair, scalp and micronutrient traits plus 14 to 16 traits for medication sensitivity and patterns of baldness. It also includes a free first month of prescription treatment. The home page describes it as testing "that reveals which treatments will work for your unique DNA."
Claim 5: "Your genetic profile determines which ingredients will work for you."
Conclusion: Potentially misleading.
Genes can predict who goes bald, but that does not mean they can predict which drug will work for you. One genetic model, built on 40,000 men and tested on 12,000 more, separated men with severe hair loss from men with none with fair accuracy (an AUC of 0.78, where 0.5 is chance and 1.0 is perfect) [4]. However, the model was never tested against treatment outcomes.

Figure 1: How accurately genes predict baldness. Source: Hagenaars et al., PLoS Genet 2017 [4].
The drug response studies are small. A 2019 study that genotyped 42 men given dutasteride for 6 months found that there were differences in six genes, especially DHRS9 and CYP26B1 that were shown to respond better to treatment [17]. Happy Head's dutasteride trait uses only SRD5A1 and SRD5A2, just 1 of which appears on that study's list. In another study from 2019, androgen receptor gene length was linked to how 25 patients in the study responded to finasteride [18]. It’s important to note that while the results are interesting, neither study is large enough to make general prescription recommendations.
Happy Head does list out the research that backs treatments for each trait on its StrandIQ clinical references page (accessed November, 2016). Though, most of the papers about finasteride focused on prostate cancer, prostate enlargement, or enzyme structure, and aren’t specifically about finasteride in response to hair loss.
Happy Head lists the papers behind each trait on its StrandIQ clinical references page (accessed November 2026). That said, the majority of the papers for the finasteride trait are about prostate cancer and enlargement, or the enzyme’s structure. None of them tested finasteride response in hair loss. The research cited for retinoic acid trait covers skin aging, cancer, and the levels of retinoic acid in newborns.
Minoxidil has the strongest case for response testing. Researchers measured SULT1A1 enzyme activity directly in plucked hairs and reported 95% sensitivity and 73% specificity for predicting response to minoxidil treatment [5]. A later analysis found the test ruled out 95.9% of nonresponders [19]. A 2010 study showed that known SULT1A1 gene variants did not fully explain differences in enzyme activity [20], so the StrandIQ DNA cheek swab is weaker than an enzyme test for determining the best treatment option.
Our recommendation: Start with a diagnosis, take photos when you begin treatment, use a proven treatment and then make adjustments based on the response and side effects you experience. Ulo, unlike many providers, personalizes by drug, strength, and formula, and includes ongoing provider access.
Concern #2: Topical Latanoprost
Both ProBlendRx topicals list 0.005% latanoprost (a prostaglandin drug used in glaucoma eye drops), and the BeardRx formula also contains the drug as well. Evidence supporting latanoprost as a hair-loss treatment is thin. A 2012 pilot trial of 16 men with mild hair loss applied latanoprost 0.1% to 1 small scalp zone and placebo to another for 24 weeks [21]. Hair density rose on the latanoprost zone, but the trial was tiny and used a strength 20 times higher than Happy Head's. A 2018 trial in 123 men and women found that 0.005% latanoprost improved hair counts. In the same trial, with only about 20 people per group, 0.010% latanoprost did not improve hair counts [22].
Latanoprost is primarily used as an eye medicine and its side effects include the possibility of changing eye color. In a 5-year study of 380 glaucoma patients, most had no increase in iris pigmentation, but among those whose iris color did change, 74% saw it begin within the first 8 months [23]. No long-term studies exist on daily latanoprost use for hair loss.
Our recommendation: Leave latanoprost out of daily scalp products until better trials exist. Ulo’s topical dutasteride doesn’t contain any latanoprost whatsoever.
Concern #3: Propylene Glycol
Propylene glycol (a solvent that dissolves minoxidil) is listed as an inactive ingredient in Happy Head's dutasteride and minoxidil topical. However, in a 2002 report, patch testing of minoxidil users with itchy, scaly scalps found propylene glycol, not minoxidil, to be the allergen in most cases [24].
Adverse reactions drive people to quit treatment. A 2023 study of 400 patients prescribed topical minoxidil found that 86.3% had stopped using it [25]. Among patients with side effects, 93.6% stopped, compared with 75.8% of patients who did not experience side effects. Happy Head offers a water-based formula for sensitive scalps, but it costs $119 as a one-time purchase, compared with $79 for Happy Head’s standard finasteride version.
Our recommendation: Make a propylene-glycol-free base with a price similar to the standard formula your default. Ulo's topical dutasteride is made without propylene glycol.
Concern #4: Corticosteroids
Happy Head lists 1% hydrocortisone as an active ingredient in its finasteride and minoxidil topicals. The company also states that the dutasteride version uses hydrocortisone as an added ingredient because it "prevents irritation and redness." That may be true in the short term, but these solutions are applied twice a day for years, which could lead to unexpected problems.
A 2011 study applied 1% hydrocortisone cream twice daily for 4 weeks to the foreheads of patients with atopic dermatitis [26]. After only 2 weeks, the outer skin layer thinned, but it returned to normal 4 weeks after ending treatment. A review from 2006 listed skin thinning, stretch marks, rosacea, perioral dermatitis, acne and easy bruising as the most frequent side effects of using topical steroids over the long-term [27]. No study has tested daily hydrocortisone use on the scalp over the number of years that hair loss treatment requires.
Our recommendation: Deal with irritation by changing the base and avoid products that contain steroids, especially if you are going to use a product every day for years. Ulo's topical dutasteride contains no corticosteroids, and you can instead choose a blend with 1% cetirizine, an antihistamine.
Concern #5: Dutasteride Formulation
A 2026 crossover study showed that the body absorbed 73% as much dutasteride from a hard gelatin capsule and 76% as much from a tablet as it did from a softgel. The researchers concluded that the formula does actually shape how much dutasteride the body absorbs [1].
Happy Head describes its oral dutasteride as ‘freshly compounded’, and neither page that covers the capsules mentions softgels specifically, meaning a powder-filled capsule could be more like the hard capsule in the 2016, but no absorption data specifically exists for Happy Head’s version.
The 3-in-1 design adds a second problem. In a multicenter study, doctors adjusted the minoxidil dose in 1,065 of 1,404 patients, and the most common side effect was unwanted body hair growth (hypertrichosis) in 15.1% of the patients [15]. If minoxidil’s side effects appear when using a minoxidil and dutasteride capsule, stopping that treatment will cause you to quit using dutasteride as well, unless you change to a dutasteride-only drug.
Our recommendation: Use a softgel form of dutasteride, and keep the minoxidil separate. Ulo's oral dutasteride comes as softgels in 0.5-, 1.5- or 2.5-mg doses, and minoxidil is an optional separate tablet at 1.25, 2.5 or 5 mg.
Can Prescription Vendors Do Better?
In our view, the effectiveness of personalized treatments rests on the type and extent of your hair loss, how well your body handles each drug, and having a plan for adjusting doses. Putting a lot of ingredients into one bottle can make it challenging to tell which one is causing issues if side effects appear.
Ulo was built with this in mind and offers a topical dutasteride at 0.2% strength or at a low-dose 0.02 strength. The low-dose option even has a published certificate of analysis, and all product pages also clearly state that our topical dutasteride contains no propylene glycol, corticosteroids or latanoprost.
The dutasteride 0.02% option is within the range tested in the 2025 trial [9]. You can try it as a standalone treatment, add 7% minoxidil (with or without 0.01% tretinoin) or even use a blend of melatonin, caffeine and cetirizine. The stronger dutasteride 0.2% formula costs $55 a month on a 12-month plan and $79 for a 1-month purchase. Dutasteride 0.02% costs from $48 to $69. Treatments come with a 365-day money-back guarantee, compared with Happy Head's refund of only the most recent month's supply.
For oral treatment, Happy Head's standalone 0.5-mg dutasteride is a few dollars cheaper per month than Ulo's, which runs $37 to $49 a month. The difference with Ulo, however, is that you buy a better-absorbed softgel at 3 dose levels, with minoxidil sold separately to reduce the risk of suffering from side effects. These are important differences to consider when you are taking a drug daily for years.
Offer ends Friday, November 20
Ulo is better than Happy Head.
Plus up to $120 in free gifts with select plans.
Available if prescribed*
Your plan ships with a bundle of Ulo hair care essentials at no extra cost. Longer plans unlock bigger bundles, while supplies last.
*Only available in the U.S. Prescriptions not guaranteed. Restrictions apply. Off-label products are not endorsed by the FDA. Free gifts included with eligible multi-month plans while supplies last.
Final Thoughts
Happy Head offers access to dutasteride and oral minoxidil, and provides help from qualified dermatologists. The company is also more open about their formulations than many competitors; most of the problems we covered in this article are common across all telehealth hair-loss treatment brands, so Happy Head is by no means unique. It's important to ask the same questions about evidence and formulas wherever you end up getting your treatments.
Happy Head offers solid options for dutasteride and oral minoxidil. They also provide access to qualified dermatologists, which not all telehealth providers do. If you’ve been a Happy Head customer with good results, and no irritation, that’s fine. If you’re just starting out or your scalp is reacting to the formula you take now, Ulo's topical dutasteride is a great option to consider for its propylene-glycol-free base and low-dose formula. Ulo's oral dutasteride is another option, if you prefer softgels with minoxidil kept separate.
References
- Fossler M, Zhu J, Roehrborn C, McAleese P, Manyak M. Impact of formulation on the pharmacokinetics of dutasteride: results from two phase I studies. Clin Drug Investig. 2016;36(9):763-767. https://doi.org/10.1007/s40261-016-0419-6
- Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://doi.org/10.1016/j.jaad.2006.05.007
- Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017;83(1):47-54. https://doi.org/10.4103/0378-6323.188652
- Hagenaars SP, Hill WD, Harris SE, Ritchie SJ, Davies G, Liewald DC, et al. Genetic prediction of male pattern baldness. PLoS Genet. 2017;13(2):e1006594. https://doi.org/10.1371/journal.pgen.1006594
- Goren A, Castano JA, McCoy J, Bermudez F, Lotti T. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia. Dermatol Ther. 2014;27(3):171-173. https://doi.org/10.1111/dth.12111
- Shin HS, Won CH, Lee SH, Kwon OS, Kim KH, Eun HC. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol. 2007;8(5):285-290. https://doi.org/10.2165/00128071-200708050-00003
- Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489-498.e3. https://doi.org/10.1016/j.jaad.2013.10.049
- Zhou Z, Song S, Gao Z, Wu J, Ma J, Cui Y. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clin Interv Aging. 2019;14:399-406. https://doi.org/10.2147/CIA.S192435
- Panuganti VK, Kumar Madala P, Ramalingayya Grandhi V, Varma Alluri C, Mohammad J, Rao Kssvv S, Reddy Dundigalla M. A randomized, double-blind, placebo and active controlled phase II study to evaluate the safety and efficacy of novel dutasteride topical solution (0.01%, 0.02%, and 0.05% w/v) in male subjects with androgenetic alopecia. Cureus. 2025;17(8):e89309. https://doi.org/10.7759/cureus.89309
- Clark RV, Hermann DJ, Cunningham GR, Wilson TH, Morrill BB, Hobbs S. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://doi.org/10.1210/jc.2003-030330
- Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Relative efficacy of minoxidil and the 5-α reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis. JAMA Dermatol. 2022;158(3):266-274. https://doi.org/10.1001/jamadermatol.2021.5743
- Almeziny A, Alghamdi A, Alajlan A, Almarhab NA, Almatham AE, Shaheen EA, Altalhab S, Alkhalifah AI. Effectiveness and safety of intralesional dutasteride in patients with androgenic alopecia: a systematic review and meta-analysis. J Cosmet Dermatol. 2025;24(12):e70560. https://doi.org/10.1111/jocd.70560
- Ghonemy S, Alarawi A, Bessar H. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. J Dermatolog Treat. 2021;32(2):236-241. https://doi.org/10.1080/09546634.2019.1654070
- Piraccini BM, Blume-Peytavi U, Scarci F, Jansat JM, Falqués M, Otero R, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. https://doi.org/10.1111/jdv.17738
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. https://doi.org/10.1016/j.jaad.2021.02.054
- Saini K, Mysore V. Role of vitamin D in hair loss: a short review. J Cosmet Dermatol. 2021;20(11):3407-3414. https://doi.org/10.1111/jocd.14421
- Rhie A, Son HY, Kwak SJ, Lee S, Kim DY, Lew BL, et al. Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia. PLoS One. 2019;14(9):e0222533. https://doi.org/10.1371/journal.pone.0222533
- Ghassemi M, Ghaffarpour GH, Ghods S. The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia. J Res Med Sci. 2019;24:104. https://doi.org/10.4103/jrms.JRMS_27_19
- Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z, Pietrzak A, Lotti T. Clinical utility and validity of minoxidil response testing in androgenetic alopecia. Dermatol Ther. 2015;28(1):13-16. https://doi.org/10.1111/dth.12164
- Yu X, Dhakal IB, Beggs M, Edavana VK, Williams S, Zhang X, et al. Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol Sci. 2010;118(2):391-403. https://doi.org/10.1093/toxsci/kfq296
- Blume-Peytavi U, Lönnfors S, Hillmann K, Garcia Bartels N. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia. J Am Acad Dermatol. 2012;66(5):794-800. https://doi.org/10.1016/j.jaad.2011.05.026
- Bloch LD, Escudeiro CC, Sarruf FD, Valente NYS. Latanoprost and minoxidil: comparative double-blind, placebo-controlled study for the treatment of hair loss. Surg Cosmet Dermatol. 2018;10(1):39-43. https://doi.org/10.5935/scd1984-8773.20181011015
- Alm A, Schoenfelder J, McDermott J. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch Ophthalmol. 2004;122(7):957-965. https://doi.org/10.1001/archopht.122.7.957
- Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46(2):309-312. https://doi.org/10.1067/mjd.2002.119104
- Shadi Z. Compliance to topical minoxidil and reasons for discontinuation among patients with androgenetic alopecia. Dermatol Ther (Heidelb). 2023;13(5):1157-1169. https://doi.org/10.1007/s13555-023-00919-x
- Aschoff R, Schmitt J, Knuschke P, Koch E, Bräutigam M, Meurer M. Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography. Exp Dermatol. 2011;20(10):832-836. https://doi.org/10.1111/j.1600-0625.2011.01335.x
- Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15. https://doi.org/10.1016/j.jaad.2005.01.010
Posted in Hair Growth Treatment